Showing results (81-90 of 119) with videos related to
Sort By:
Pageof 12
Biomaterials|September 1, 2022
Functional imaging and targeted drug delivery in mice and patient tumors with a cell nucleolus-localizing and tumor-targeting peptideRenwei Jing, Qian Wang, Lu Chen, et al.Cell Death & Disease|September 26, 2018
High PGAM5 expression induces chemoresistance by enhancing Bcl-xL-mediated anti-apoptotic signaling and predicts poor prognosis in hepatocellular carcinoma patientsJingjing Cheng, Dong Qian, Xiaofeng Ding, et al.Journal of Hepatocellular Carcinoma|May 1, 2023
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular CarcinomaLeijuan Gan, Mengran Lang, Xindi Tian, et al.American Journal of Cancer Research|July 10, 2023
Lenvatinib plus sintilimab with or without transarterial chemoembolization for intermediate or advanced stage hepatocellular carcinoma: a propensity score-matching cohort studyMengran Lang, Leijuan Gan, Shaohua Ren, et al.Hepatology (Baltimore, Md.)|October 2, 2014
Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinomaLian Li, Yuexin Liu, Yan Guo, et al.World Journal of Surgery|January 6, 2023
A Bayesian Network Prediction Model for Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma: A Multi-institutional StudyQi Li, Jingwei Zhang, Zhiqiang Cai, et al.Cell Death & Disease|November 28, 2025
Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5Lu Chen, Zhiqiang Han, Xiangdong Tian, et al.Cell Death & Disease|May 23, 2022
DNAJC24 is a potential therapeutic target in hepatocellular carcinoma through affecting ammonia metabolismGuangtao Li, Yuchao He, Hui Liu, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2020
Survival prediction for gallbladder carcinoma after curative resection: Comparison of nomogram and Bayesian network modelsYuhan Wu, Qi Li, Zhiqiang Cai, et al.Bioscience Trends|December 9, 2021
Elevated serum CA19-9 indicates severe liver inflammation and worse survival after curative resection in hepatitis B-related hepatocellular carcinomaWei Zhang, Yingying Wang, Xiang Dong, et al.Pageof 12